Key Speakers Include:

Advance Cancer Detection, Prognosis & Treatment with Biomarker Discovery, Validation and Practical Applications in Clinical Trials

Biomarkers have become one of the most important tools to detect and monitor disease progressions and they have been playing important roles in cancer diagnostics, treatments and drug development.

Pharmaceutical and biotech companies are putting tremendous effort in the research of the discovery and management of biomarkers; however, there is a lot to be done on the qualification, validation and applications of the biomarkers. The impact of the biomarkers on the pharmacology is yet to be discovered.

Cutting-edge technologies of Proteomics, Genomics and Imaging will be presented. Practical case studies coupled with recent regulatory updates and their impact on the applications are making this event a great learning opportunity that you don’t want to miss!

insert3


Who should attend:

VPs / Directors / Heads of:

  • CSO (Chief Scientific Officer)
  • Research & Development
  • Molecular Medicine
  • Biomarkers
  • Biochemical and Molecular Biomarkers
  • Experimental Biological Sciences/Experimental Medicine
  • Biomarker and Translational Medicine
  • Clinical Pharmacology and Experimental Medicine
  • Genomics
  • Proteomics
  • Pharmacogenomics
  • Bioinformatics
  • Imaging
  • Oncology
  • Cancer
  • Screening
  • Pre-Clinical Research
  • Clinical Chemistry
  • Toxicity

From Pharmaceutical, Biotech and Cancer Research Institutions


webcast_icon

Webcasts

Sponsor Media Partners
Sponsors mediapartners